Impact of Rituximab on Magnetic Resonance Imaging Evidence of Synovitis and Bone Lesions in Patients With Moderate or Severe Rheumatoid Arthritis
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms IMPRESS
- 17 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Jun 2011 Planned end date changed from 1 Feb 2009 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 17 Feb 2007 New trial record.